Overview
DISSECT-N is a post-market registry designed to assess real-world safety and effectiveness of Valiant Navion Thoracic Stent Graft System in the treatment of thoracic aortic dissections in real world practice.
Description
DISSECT-N is a prospective, observational, global, multi-center, post-market registry designed to assess real-world safety and effectiveness of Valiant Navion Thoracic Stent Graft System in the treatment of thoracic aortic dissections in real world practice.
Eligibility
Inclusion Criteria:
- Subject is 18 years old
- Subject was treated in the last 7 days, or is intended to be treated, with the Valiant Navion Thoracic Stent Graft System for a dissection in the thoracic aorta
- Subject is willing to comply with standard of care clinical follow-up
- Subject or legal representative has consented for study participation and signed the approved Informed Consent
Exclusion Criteria:
- Subject is participating in an investigational drug or device study which may bias or interfere with the endpoints and follow-up of this study.
- Subject is pregnant (not an exclusion if allowed per local regulatory requirements, pregnancy test to be performed where required)